Please Wait
Applying Filters...
menu
    • menu
    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    An Enquiry

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.https://marketing.lgmpharma.com/LGM-CDMO

    Virtual Booth

    Contact Supplier

    Vamsi Labs is one of the major manufacturers of Anti-asthmatic, Anti-migraine & Anti-psychotic APIs.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    An Enquiry

    Menu

    Netupitant

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 16,900Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Helsinn, Magnapharm Strike Long-Term Deal For AKYNZEO & ALOXI
    Helsinn, Magnapharm Strike Long-Term Deal For AKYNZEO & ALOXI

    11 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/11/3236025/0/en/Helsinn-and-MagnaPharm-enter-long-term-agreement-for-AKYNZEO-and-ALOXI-across-five-Central-and-Eastern-European-countries.html

    GLOBENEWSWIRE
    11 Feb 2026
    Share Share
    Helsinn, ESTEVE Extend AKYNZEO® And ALOXI® Agreement To Austria
    Helsinn, ESTEVE Extend AKYNZEO® And ALOXI® Agreement To Austria

    09 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/09/3234320/0/en/Helsinn-and-ESTEVE-expand-their-partnership-extending-the-Distribution-and-Licence-Agreement-for-AKYNZEO-and-ALOXI-to-Austria.html

    GLOBENEWSWIRE
    09 Feb 2026
    Share Share
    Akynzeo Beats Standard Care in Preventing Chemo Nausea
    Akynzeo Beats Standard Care in Preventing Chemo Nausea

    17 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/17/3168493/0/en/AKYNZEO-demonstrates-superior-prevention-of-chemotherapy-induced-nausea-and-vomiting-compared-to-the-standard-of-care-in-patients-receiving-moderately-emetogenic-chemotherapy-with-.html

    GLOBENEWSWIRE
    17 Oct 2025
    Share Share
    Helsinn Group submits new Akynzeo formulation to EMA
    Helsinn Group submits new Akynzeo formulation to EMA

    02 Apr 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/04/02/3054025/0/en/Helsinn-Group-submits-a-new-formulation-of-AKYNZEO-to-the-European-Medicines-Agency-EMA.html

    GLOBENEWSWIRE
    02 Apr 2025
    Share Share
    Helsinn, Esteve Renew Partnership To Commercialize AKYNZEO, ALOXI
    Helsinn, Esteve Renew Partnership To Commercialize AKYNZEO, ALOXI

    08 Jan 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/01/08/3006010/0/en/Helsinn-Group-and-ESTEVE-sign-a-partnership-agreement-renewal-to-commercialize-AKYNZEO-and-ALOXI-in-Germany.html

    GLOBENEWSWIRE
    08 Jan 2025
    Share Share
    Helsinn & Chugai sign a partnership agreement renewal to commercialize AKYNZEO
    Helsinn & Chugai sign a partnership agreement renewal to commercialize AKYNZEO

    12 Jun 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/06/12/2897362/0/en/Helsinn-Group-and-Chugai-Pharma-Europe-sign-a-partnership-agreement-renewal-to-commercialize-AKYNZEO-in-the-UK-and-Ireland.html

    GLOBENEWSWIRE
    12 Jun 2024
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.